The Impact of Generic Biotech Products on the Healthcare Supply Chain | SupplyChainBrain

The Impact of Generic Biotech Products on the Healthcare Supply Chain

Gillian Woollett Icon

Lower-cost "biosimilars" are coming to the U.S. Gillian Woollett, chief scientist with Engel & Novitt, LLP, discusses the implications for drug companies, supply-chain managers and patients. [Run Time (Min:) 7:58]


Viewthe Video Button 01

Related Content

Related Videos

Featured Product

More in All Logistics
Page 1 of 957
Next Page

Visit Our Sponsors